Business Context and Reporting Period
Company: Ecolab Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 7, 2007
Event: Announcement of a definitive agreement and plan of merger to acquire Microtek Medical Holdings, Inc.
Key Financial Metrics
This filing is a current report regarding a corporate transaction and does not contain Ecolab Inc.'s periodic financial statements (revenue, profit, cash flow, margins, debt, or liquidity). The only specific financial metric disclosed relates to the acquisition terms:
- Acquisition Price: $6.30 per share in cash for all outstanding shares of Microtek Medical Holdings, Inc.
Material Changes
The material change reported is the entry into a definitive merger agreement. The transaction involves Ecolab acquiring Microtek Medical Holdings, Inc. The completion of the merger is subject to:
- Approval by Microtek's shareholders.
- Other customary closing conditions, including regulatory approvals.
Guidance, Outlook, and Risks
Management Commentary: Ecolab has initiated the solicitation of proxies from Microtek stockholders in favor of the merger. Participants in the solicitation include Ecolab, Microtek, and their respective directors, executive officers, and certain management members.
Risks and Contingencies: The transaction is not yet closed and is contingent upon shareholder approval and regulatory clearance. Investors are directed to review the upcoming proxy statement for detailed risk factors and transaction specifics.
Investor Verification Checklist
- Verify the final approval status of the merger by Microtek shareholders.
- Confirm receipt of necessary regulatory approvals for the transaction.
- Review the Microtek proxy statement for detailed financial data on the target company and specific terms of the merger.
- Check for any subsequent filings regarding the closing of the transaction or changes to the $6.30 per share offer price.